PM
CPIX icon

Platinum Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Platinum Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-24,800
Closed -$148K – 8
2014
Q4 		$148K Buy
+24,800
New +$127K 0.32% 11

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Platinum Management's CPIX Position: Q1 2015 in Review

Platinum Management sold out of Cumberland Pharmaceuticals (CPIX) in Q1 2015, closing a stake of 24,800 shares — an estimated $148K sold.

Platinum Management first reported a position in CPIX in Q4 2014 and held it in 1 quarter. The position peaked at $148K in Q4 2014. 46 funds tracked by Wall St. Rank hold CPIX as of Q1 2015.

  • Platinum Management reported no remaining Cumberland Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Platinum Management sold 24,800 Cumberland Pharmaceuticals shares in Q1 2015, an estimated $148K.
  • Platinum Management first reported a position in Cumberland Pharmaceuticals in Q4 2014 and held it in 1 quarter.
  • Platinum Management's Cumberland Pharmaceuticals position peaked at $148K in Q4 2014.
  • 46 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2015.

Based on Platinum Management's 13F filing for Q1 2015, filed 15 May 2015.